Literature DB >> 12111037

The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning.

Charles Steenbergen1.   

Abstract

Myocardial mitogen-activated protein kinases can be activated by ischemia and reperfusion, and they may play important roles in the evolution of ischemic injury. Considerable work has been performed to evaluate the role of different MAPK signaling pathways in ischemia/reperfusion injury. The focus of this review is the p38 MAPK pathway, specifically whether activation of the p38 MAPK signaling pathway is beneficial or detrimental. Different studies have come to conflicting conclusions. This review will examine the literature on the role of p38 MAPK in myocardial ischemia/reperfusion injury, highlight areas of controversy and areas of general agreement, examine possible downstream targets of p38 during acute ischemia, and attempt to draw some conclusions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111037     DOI: 10.1007/s00395-002-0364-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  33 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

3.  Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.

Authors:  Norbert Fülöp; Zhenghao Zhang; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-05       Impact factor: 4.733

4.  Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

Authors:  D Westermann; S Rutschow; S Van Linthout; A Linderer; C Bücker-Gärtner; M Sobirey; A Riad; M Pauschinger; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2006-08-26       Impact factor: 10.122

5.  SDF-1 induces TNF-mediated apoptosis in cardiac myocytes.

Authors:  Andrew A Jarrah; Martina Schwarskopf; Edward R Wang; Thomas LaRocca; Ashwini Dhume; Shihong Zhang; Lahouria Hadri; Roger J Hajjar; Alison D Schecter; Sima T Tarzami
Journal:  Apoptosis       Date:  2018-01       Impact factor: 4.677

Review 6.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

7.  Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats.

Authors:  Anzhou Xia; Yong Li; Na Li; Zhi Xue; Jieyun Xia; Tiantian Wei; Jing Cao
Journal:  Int Urol Nephrol       Date:  2014-06-14       Impact factor: 2.370

8.  S-propranolol protected H9C2 cells from ischemia/reperfusion-induced apoptosis via downregultion of RACK1 Gene.

Authors:  Xiongfei Jia; Li Zhang; Xiaoqin Mao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Metformin mitigates apoptosis in ischemic myocardium.

Authors:  Nassrene Y Elmadhun; Ashraf A Sabe; Antonio D Lassaletta; Louis M Chu; Frank W Sellke
Journal:  J Surg Res       Date:  2014-05-17       Impact factor: 2.192

10.  Effect of p38 MAP kinases on contractility and ischemic injury in intact heart.

Authors:  H R Cross; M Li; B G Petrich; E Murphy; Y Wang; Charles Steenbergen
Journal:  Acta Physiol Hung       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.